Fusion Research
Research analyst, oil & gas, tech, mid-cap

Unilife: Is 2013 The Tipping Point For This Pharma Stock?

The next wave of technological advancement in biotechnology and the pharma industry is about bringing convenience and ease to the administration of drugs. The growth in the injectable market and increasing awareness of self-administration are driving pharma companies to come up with new and innovative products with increased drug delivery convenience and safety. In the customized medical injectable market, one company that has started gaining traction is Unilife (UNIS).

Understanding the business:

The company is in the business of design, development, manufacturing, and supply of injectable products. Its products are designed with focus on safety that removes risk of needle-stick injury and unsafe injection practices.

Unilife has four main sources of revenue:

1. Customization program: In this...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details